Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15542165 | 0.89 | KCNN4 (1.00) | KCNN4ALDH1A1 | |
| SCHEMBL15542319 | 0.89 | KCNN4 (1.00) | KCNN4 | |
| SCHEMBL15540963 | 0.89 | KCNN4 (1.00) | KCNN4ALDH1A1 | |
| SCHEMBL15542680 | 0.89 | KCNN4 (1.00) | KCNN4 | |
| SCHEMBL15542461 | 0.88 | KCNN4 (1.00) | KCNN4ALDH1A1 | |
| SCHEMBL16919487 | 0.86 | KCNN4 (0.75) | KCNN4ALDH1A1 | |
| SCHEMBL15542327 | 0.86 | KCNN4 (1.00) | KCNN4ALDH1A1 | |
| SCHEMBL4211677 | 0.80 | KCNN4 (0.66) | KCNN4ALDH1A1 | |
| SCHEMBL15542105 | 0.76 | KCNN4 (1.00) | KCNN4 | |
| SCHEMBL8653700 | 0.75 | KCNN4 (0.60) | KCNN4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2867215-B1 | TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA AS (DK) | 2018-07-18 | — | — | EP | claimed |
| CN-104487427-B | tetrazole derivatives and their use as potassium channel modulators | 萨尼奥纳有限责任公司 | 2017-03-15 | — | — | CN | claimed |
| US-20150203458-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-07-23 | — | — | US | claimed |
| EP-2867215-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-05-06 | — | — | EP | claimed |
| WO-2014001363-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | CLEVEXEL PHARMA (FR) | 2014-01-03 | — | — | WO | claimed |
| EP-2867215-B1 | TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA AS (DK) | 2018-07-18 | — | — | EP | disclosed |
| CN-104487427-B | tetrazole derivatives and their use as potassium channel modulators | 萨尼奥纳有限责任公司 | 2017-03-15 | — | — | CN | disclosed |
| US-9556132-B2 | Tetrazole derivatives and their use as potassium channel modulators | SANIONA A/S (DK) | 2017-01-31 | — | — | US | disclosed |
| US-9556132-B2 | Tetrazole derivatives and their use as potassium channel modulators | SANIONA A/S (DK) | 2017-01-31 | — | — | US | disclosed |
| US-9556132-B2 | Tetrazole derivatives and their use as potassium channel modulators | SANIONA A/S (DK) | 2017-01-31 | — | — | US | disclosed |
| US-20150203458-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-07-23 | — | — | US | disclosed |
| US-20150203458-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-07-23 | — | — | US | disclosed |
| US-20150203458-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-07-23 | — | — | US | disclosed |
| EP-2867215-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | SANIONA APS (DK) | 2015-05-06 | — | — | EP | disclosed |
| WO-2014001363-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | CLEVEXEL PHARMA (FR) | 2014-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203458-A1 | NOVEL TETRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | KCNJ2, KCNN2, KCNA1 | KCNN4 54/4885ALDH1A1 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.